Fuchs (XTRA:FPE3) has moved back into focus after reporting nine-month 2026 results and updating guidance, with sales of €3,126 million and net income of €281 million.
The raised 2026 guidance and third quarter earnings beat have come alongside a share price of €44.28, with a 30-day share price return of 3.75% and a 90-day gain of 8.74%, suggesting positive momentum, while the 1-year total shareholder return of 17.82% points to solid longer term compounding.
Scan how Fuchs compares to other materials stocks showing earnings momentum and pricing power by reviewing the curated 197 high quality undervalued stocks in the same space.
Fuchs now appears to be a stronger business at €44.28 following its upgraded 2026 guidance and earnings beat. The key question is whether that improved story is already fully reflected in the valuation.
Most Popular Narrative: 7% Undervalued
On the most followed narrative, Fuchs screens as modestly undervalued, with a fair value of €47.56 against the recent €44.28 share price. This narrative places more weight on Asia Pacific, margins and cash generation than on near term trading momentum.
The thesis on Fuchs has been reviewed and reaffirmed, with the narrative now placing more weight on the contribution of Asia Pacific, the FUCHS100 focus on six segments, and the capital light, cash generative model as key supports for revenue, EBIT and margin resilience.
The fair value estimate has been slightly reduced from €49.51 to €47.56, reflecting a modest adjustment to the long term view on the shares.
See why 8 investors see Fuchs as 7% undervalued.
Result: Fair Value of €47.56 (UNDERVALUED)
Still, the Fuchs story can be challenged if prolonged weakness in Europe and the Americas reduces volumes, or if a shift in product mix quietly squeezes margins.
Find out about the key risks to this Fuchs narrative.
Next Steps
If this narrative around Fuchs feels balanced but incomplete, act quickly and compare it with the underlying numbers yourself. Then weigh those positives by checking the 3 key rewards.
Looking for more investment ideas beyond Fuchs?
If Fuchs feels like one piece of your watchlist, you can broaden your opportunity set with a few targeted stock lists built from hard numbers, not headlines.
-
Target resilient compounding potential by scanning companies that currently screen as 197 high quality undervalued stocks.
-
Prioritise balance sheet strength and financial resilience by reviewing a curated list of solid balance sheet and fundamentals (199 results) before the crowd catches on.
-
Get ahead of the market by tracking a focused group of 611 high quality undiscovered gems that many investors are likely overlooking right now.
